AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+13.09%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$11.3B
AUM Growth
+$1.07B
(+10%)
Cap. Flow
-$118M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
43.92%
Holding
930
New
74
Increased
169
Reduced
352
Closed
28
Top Buys
| 1 |
ChargePoint
CHPT
|
$42.7M |
| 2 |
Enterprise Products Partners
EPD
|
$38.3M |
| 3 |
Shoals Technologies Group
SHLS
|
$25.8M |
| 4 |
JNPR
Juniper Networks
JNPR
|
$24M |
| 5 |
CEQP
Crestwood Equity Partners LP
CEQP
|
$23.2M |
Top Sells
| 1 |
Energy Transfer Partners
ET
|
$86.2M |
| 2 |
NBLX
Noble Midstream Partners LP
NBLX
|
$65.5M |
| 3 |
Plains All American Pipeline
PAA
|
$55M |
| 4 |
Xerox
XRX
|
$20.9M |
| 5 |
Acuity Brands
AYI
|
$20.6M |
Sector Composition
| 1 | Energy | 52.67% |
| 2 | Financials | 10.26% |
| 3 | Technology | 6.92% |
| 4 | Healthcare | 4.76% |
| 5 | Consumer Discretionary | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Target
TGT
$42.3B
| $3.42M | 0.03% |
14,128
-186
| -1% | -$45K |
|
202
Chemed
CHE
$6.79B
| $3.37M | 0.03% |
7,110
-200
| -3% | -$94.9K |
|
203
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.5B
| $3.37M | 0.03% |
29,960
-440
| -1% | -$49.5K |
|
204
Amicus Therapeutics
FOLD
$2.46B
| $3.36M | 0.03% |
+348,441
| New | +$3.36M |
|
205
S&P Global
SPGI
$164B
| $3.34M | 0.03% |
8,132
-269
| -3% | -$110K |
|
206
Cannae Holdings
CNNE
$1.09B
| $3.33M | 0.03% |
98,300
-3,000
| -3% | -$102K |
|
|
MOR
207
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $3.32M | 0.03% |
172,594
-65,423
| -27% | -$1.26M |
|
|
MIC
208
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $3.24M | 0.03% |
84,643
+6,033
| +8% | +$231K |
|
209
Meta Platforms (Facebook)
META
$1.89T
| $3.23M | 0.03% |
9,299
+919
| +11% | +$320K |
|
210
FibroGen
FGEN
$48.9M
| $3.22M | 0.03% |
4,834
-1,792
| -27% | -$1.19M |
|
211
Vericel Corp
VCEL
$1.72B
| $3.19M | 0.03% |
60,756
-22,387
| -27% | -$1.18M |
|
212
Bank of America
BAC
$369B
| $3.12M | 0.03% |
75,547
-3,922
| -5% | -$162K |
|
213
Apollo Global Management
APO
$75.3B
| $3.07M | 0.03% |
49,300
-2,200
| -4% | -$137K |
|
214
Coca-Cola
KO
$292B
| $3.05M | 0.03% |
56,442
-2,719
| -5% | -$147K |
|
|
VMW
215
DELISTED
VMware, Inc
VMW
| $2.98M | 0.03% |
18,636
-477
| -2% | -$76.3K |
|
216
Prothena Corp
PRTA
$460M
| $2.98M | 0.03% |
57,880
-14,337
| -20% | -$737K |
|
217
Liberty Broadband Class C
LBRDK
$8.61B
| $2.97M | 0.03% |
17,100
-3,500
| -17% | -$608K |
|
218
ResMed
RMD
$40.6B
| $2.94M | 0.03% |
11,924
-978
| -8% | -$241K |
|
219
Danaher
DHR
$143B
| $2.92M | 0.03% |
12,292
+254
| +2% | +$60.4K |
|
220
Zoetis
ZTS
$67.9B
| $2.92M | 0.03% |
15,668
+17
| +0.1% | +$3.17K |
|
221
Skyworks Solutions
SWKS
$11.2B
| $2.9M | 0.03% |
15,098
+1,264
| +9% | +$242K |
|
222
Zoom
ZM
$25B
| $2.89M | 0.03% |
7,473
+630
| +9% | +$244K |
|
223
ALX Oncology
ALXO
$65.3M
| $2.88M | 0.03% |
+52,682
| New | +$2.88M |
|
224
Carlyle Group
CG
$23.1B
| $2.88M | 0.03% |
61,900
-1,900
| -3% | -$88.3K |
|
225
Ligand Pharmaceuticals
LGND
$3.25B
| $2.86M | 0.03% |
34,984
-11,639
| -25% | -$953K |
|